发明名称 |
Low dose estrogen interrupted hormone replacement therapy |
摘要 |
A hormone replacement therapy, comprising a plurality of daily doses of a pharmaceutical preparation, the doses being administered continuously and consecutively in alternating phases of three daily doses, a relatively dominant estrogenic activity phase comprising three daily doses of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17beta-estradiol per day, and a relatively dominant progestagenic activity phase of a combination of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17beta-estradiol and a substance exhibiting progestogenic activity equivalent to about 90 mug per day of norgestimate.
|
申请公布号 |
US7320970(B2) |
申请公布日期 |
2008.01.22 |
申请号 |
US20060439171 |
申请日期 |
2006.05.24 |
申请人 |
DURAMED PHARMACEUTIALS, INC.;JENCAP RESEARCH LTD. |
发明人 |
CASPER ROBERT F.;SHANGOLD GARY A.;AUSMANAS MILITZA K. |
分类号 |
A61K9/20;A61K31/56;A61K31/565;A61K31/566;A61K31/567;A61K31/57;A61K31/575;A61P5/24;A61P5/30;A61P15/12;A61P43/00 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|